Home > Riviste > Minerva Urologica e Nefrologica > Fascicoli precedenti > Minerva Urologica e Nefrologica 2016 December;68(6) > Minerva Urologica e Nefrologica 2016 December;68(6):586-91

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Estratti
Per citare questo articolo

MINERVA UROLOGICA E NEFROLOGICA

Rivista di Nefrologia e Urologia


Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,984


eTOC

 

REVIEWS  ENDOUROLOGIC DISEASE GROUP FOR EXCELLENCE (EDGE) RESEARCH CONSORTIUM: A PRIMER ON ADVANCED URETEROSCOPY FOR STONE DISEASE


Minerva Urologica e Nefrologica 2016 December;68(6):586-91

Copyright © 2016 EDIZIONI MINERVA MEDICA

lingua: Inglese

Understanding the costs of flexible ureteroscopy

Justin B. ZIEMBA, Brian R. MATLAGA

Brady Urological Institute, Johns Hopkins School of Medicine, Johns Hopkins University, Baltimore, MD, USA


PDF  


Ureteroscopy (URS) is the first line treatment for the majority of symptomatic renal and ureteral stones. This review summarizes the current literature on the costs associated with URS. A high initial investment is required for scope acquisition. Once purchased, maintenance and repair costs continue to accrue. Durability of the scopes is an important consideration as more durable scopes will remain functional for longer and thus have lower overall repair costs. Currently available, newer generation scopes appear highly durable compared to their predecessors. Ancillary equipment, mostly disposable items represent the highest per procedure cost of URS. Despite these costs, URS remains highly profitable. However, it is also efficacious demonstrating superior cost-effectiveness with higher stone free rates at a lower cost relative to shock wave lithotripsy.

inizio pagina

Publication History

Per citare questo articolo

Ziemba JB, Matlaga BR. Understanding the costs of flexible ureteroscopy. Minerva Urol Nefrol 2016 December;68(6):586-91. 

Corresponding author e-mail

jziemba1@jhmi.edu